Immunology

Edited by Neeraja Sankaran K.L. Rock, C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, A.L. Goldberg, "Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules," Cell, 78:761-71, 1994. (Cited in nearly 70 publications through November 1995) Comments by Kenneth Rock, Dana-Farber Cancer Institute, Boston This paper discusses the biochemistry of the cellular processes that allow the immune system to re


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by Neeraja Sankaran

K.L. Rock, C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, A.L. Goldberg, "Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules," Cell, 78:761-71, 1994. (Cited in nearly 70 publications through November 1995) Comments by Kenneth Rock, Dana-Farber Cancer Institute, Boston

This paper discusses the biochemistry of the cellular processes that allow the immune system to recognize various peptides-pieces of protein-present on the surfaces of different cells.

Kenneth Rock ON THE SURFACE: Dana-Farber Cancer Institute's Kenneth Rock and his colleagues determined how MHC-associated peptides are generated.

One of the main interests of the authors of this paper was to determine how these peptides are generated. "Our hypothesis was that the proteasome-a large, multi-subunit protein complex with protein-degrading activity-is somehow involved in breaking down foreign proteins into pieces which are then transported to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio